Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 227

1.

Recent advances in drug repositioning for the discovery of new anticancer drugs.

Shim JS, Liu JO.

Int J Biol Sci. 2014 Jun 10;10(7):654-63. doi: 10.7150/ijbs.9224. eCollection 2014. Review.

2.

An Insight into Drug Repositioning for the Development of Novel Anti-Cancer Drugs.

Bhattarai D, Singh S, Jang Y, Hyeon Han S, Lee K, Choi Y.

Curr Top Med Chem. 2016;16(19):2156-68. Review.

PMID:
26881715
3.

Computational drug repositioning for cancer therapeutics.

Jiao M, Liu G, Xue Y, Ding C.

Curr Top Med Chem. 2015;15(8):767-75.

PMID:
25732789
4.

In silico drug repositioning: what we need to know.

Liu Z, Fang H, Reagan K, Xu X, Mendrick DL, Slikker W Jr, Tong W.

Drug Discov Today. 2013 Feb;18(3-4):110-5. doi: 10.1016/j.drudis.2012.08.005. Epub 2012 Aug 28.

5.

In vitro screening for drug repositioning.

Wilkinson GF, Pritchard K.

J Biomol Screen. 2015 Feb;20(2):167-79. doi: 10.1177/1087057114563024. Epub 2014 Dec 19. Review.

PMID:
25527136
6.

Predicting new indications for approved drugs using a proteochemometric method.

Dakshanamurthy S, Issa NT, Assefnia S, Seshasayee A, Peters OJ, Madhavan S, Uren A, Brown ML, Byers SW.

J Med Chem. 2012 Aug 9;55(15):6832-48. doi: 10.1021/jm300576q. Epub 2012 Jul 25.

7.

Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compounds.

Würth R, Thellung S, Bajetto A, Mazzanti M, Florio T, Barbieri F.

Drug Discov Today. 2016 Jan;21(1):190-199. doi: 10.1016/j.drudis.2015.09.017. Epub 2015 Oct 9. Review.

PMID:
26456577
8.

Revisiting Non-Cancer Drugs for Cancer Therapy.

Yang EJ, Wu C, Liu Y, Lv J, Sup Shim J.

Curr Top Med Chem. 2016;16(19):2144-55. Review.

PMID:
26881712
9.

Computational and experimental advances in drug repositioning for accelerated therapeutic stratification.

Shameer K, Readhead B, Dudley JT.

Curr Top Med Chem. 2015;15(1):5-20. Review.

PMID:
25579574
10.

A survey of current trends in computational drug repositioning.

Li J, Zheng S, Chen B, Butte AJ, Swamidass SJ, Lu Z.

Brief Bioinform. 2016 Jan;17(1):2-12. doi: 10.1093/bib/bbv020. Epub 2015 Mar 31. Review.

11.

Drug repositioning: re-investigating existing drugs for new therapeutic indications.

Padhy BM, Gupta YK.

J Postgrad Med. 2011 Apr-Jun;57(2):153-60. doi: 10.4103/0022-3859.81870. Review.

12.

Scaffold Repurposing of Old Drugs Towards New Cancer Drug Discovery.

Chen H, Wu J, Gao Y, Chen H, Zhou J.

Curr Top Med Chem. 2016;16(19):2107-14. Review.

PMID:
26881709
13.

Importance of molecular computer modeling in anticancer drug development.

Geromichalos GD.

J BUON. 2007 Sep;12 Suppl 1:S101-18. Review.

PMID:
17935268
14.

DRUGSURV: a resource for repositioning of approved and experimental drugs in oncology based on patient survival information.

Amelio I, Gostev M, Knight RA, Willis AE, Melino G, Antonov AV.

Cell Death Dis. 2014 Feb 6;5:e1051. doi: 10.1038/cddis.2014.9.

15.

The prince and the pauper. A tale of anticancer targeted agents.

Dueñas-González A, García-López P, Herrera LA, Medina-Franco JL, González-Fierro A, Candelaria M.

Mol Cancer. 2008 Oct 23;7:82. doi: 10.1186/1476-4598-7-82. Review.

16.

Early repositioning through compound set enrichment analysis: a knowledge-recycling strategy.

Temesi G, Bolgár B, Arany A, Szalai C, Antal P, Mátyus P.

Future Med Chem. 2014 Apr;6(5):563-75. doi: 10.4155/fmc.14.4.

PMID:
24649958
17.

In silico repositioning of approved drugs for rare and neglected diseases.

Ekins S, Williams AJ, Krasowski MD, Freundlich JS.

Drug Discov Today. 2011 Apr;16(7-8):298-310. doi: 10.1016/j.drudis.2011.02.016. Epub 2011 Mar 1. Review.

PMID:
21376136
18.

Drug repositioning for personalized medicine.

Li YY, Jones SJ.

Genome Med. 2012 Mar 30;4(3):27. doi: 10.1186/gm326. eCollection 2012. Review.

19.

Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines.

Jin G, Wong ST.

Drug Discov Today. 2014 May;19(5):637-44. doi: 10.1016/j.drudis.2013.11.005. Epub 2013 Nov 14. Review.

20.

Computational and Practical Aspects of Drug Repositioning.

Oprea TI, Overington JP.

Assay Drug Dev Technol. 2015 Jul-Aug;13(6):299-306. doi: 10.1089/adt.2015.29011.tiodrrr. Review.

Supplemental Content

Support Center